Malignancy in dermatomyositis and polymyositis - UpToDate
uptodate.com · 322 words · saved by 1 readers
{{configCtrl2.metaDescription()}}
Malignancy in dermatomyositis and polymyositis INTRODUCTION Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory myopathies characterized by proximal skeletal muscle weakness and evidence of muscle inflammation. DM, unlike PM, is characterized by the presence of various cutaneous manifestations. DM and PM may also be associated with inflammatory arthritis, interstitial lung disease, Raynaud phenomenon, and the presence of autoantibodies. An association between inflammatory myopathy and cancer has been recognized since the report of two cases of PM and gastric cancer in…
related reading
- Diagnosis and differential diagnosis of dermatomyositis and polymyositis in adultsuptodate.com
- Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosisuptodate.com
- Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody - PubMedpubmed.ncbi.nlm.nih.gov
- Myotonic Dystrophy: What It Is, Symptoms, Types & Treatmentmy.clevelandclinic.org
- Clinical manifestations and diagnosis of psoriatic arthritisuptodate.com
- Cutaneous manifestations of internal malignancyuptodate.com
- ALS - Wikipediaen.wikipedia.org
- Clinical manifestations of myasthenia gravisuptodate.com
- Fibromyalgia Warsjrheum.org
- Charcot-Marie-Tooth Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Peripheral Arterial Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Evaluation of the adult with acute weakness in the emergency departmentuptodate.com